Desk›Healthcare› Himalaya Nutravedics India Ltd
Himalaya Nutravedics India Ltd
BSE 544943 · NSE HNIL · ISIN INE1OTR01013 · Group MT · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
Disclosure profile 3 filings in the window
| Tag | Filings |
|---|---|
| Procedural | |
| Clarification | 1 |
| Compliance Certificate | 1 |
| New Listing | 1 |
| Procedural sub-total | 3 |
| Total | 3 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group MT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 98 trading days
3 filings · 0 selected · busiest 2026-10-16
Filing rhythm · the twelve most recent
2026-09-292026-10-16
SelectedProcedural
Filings
3 in the window
-
16 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
for the quarter ended 30th September 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
16 October 2026 ·
Clarification sought from Himalaya Nutravedics India Ltd
The Exchange has sought clarification from Himalaya Nutravedics India Ltd on October 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....
Company Update / Clarification
-
29 September 2026 ·
Listing of Equity Shares of Himalaya Nutravedics India Ltd
Trading Members of the Exchange are hereby informed that effective from September 29, 2026, the Equity Shares of Himalaya Nutravedics India Ltd (Scrip Code: 544943) are listed and admitted ....
New Listing / New Listing
RSS feed for Himalaya Nutravedics India Ltd · the 50 most recent filings